Growth Metrics

BioNTech SE (BNTX) Receivables - Net (2018 - 2025)

Historic Receivables - Net for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to $807.6 million.

  • BioNTech SE's Receivables - Net rose 61602.42% to $807.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $807.6 million, marking a year-over-year increase of 61602.42%. This contributed to the annual value of $1.6 billion for FY2024, which is 3255.52% down from last year.
  • Per BioNTech SE's latest filing, its Receivables - Net stood at $807.6 million for Q3 2025, which was up 61602.42% from $1.5 billion recorded in Q2 2025.
  • Over the past 5 years, BioNTech SE's Receivables - Net peaked at $14.2 billion during Q1 2022, and registered a low of $10.0 million during Q1 2024.
  • In the last 5 years, BioNTech SE's Receivables - Net had a median value of $2.9 billion in 2021 and averaged $5.1 billion.
  • In the last 5 years, BioNTech SE's Receivables - Net tumbled by 9985.56% in 2024 and then soared by 996678.16% in 2025.
  • Quarter analysis of 5 years shows BioNTech SE's Receivables - Net stood at $14.2 billion in 2021, then crashed by 48.53% to $7.3 billion in 2022, then tumbled by 68.18% to $2.3 billion in 2023, then plummeted by 32.56% to $1.6 billion in 2024, then tumbled by 48.37% to $807.6 million in 2025.
  • Its Receivables - Net was $807.6 million in Q3 2025, compared to $1.5 billion in Q2 2025 and $1.0 billion in Q1 2025.